Biocon Ltd. Reveals Aggressive Fundraising Strategy to Fuel Growth

Unknown Apr 02, 2026 650 Views

Biocon Ltd., one of the largest biopharmaceutical firms, has revealed its aggressive plan to raise as much as ₹45 billion by issuing securities. This move is designed to strengthen the company's financials and finance its growth strategy. The major highlights are as follows: Fu...